Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) (Unaudited)

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) (Unaudited) - USD ($)
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2018 $ 13 $ 341,529 $ 30,669,220 $ (43,890,445) $ (12,879,683)
Beginning Balance, Shares at Dec. 31, 2018 13,000 341,529,434      
Share-based compensation from issuance of options and compensation-based warrants 43,008 43,008
Exercise of stock options
Net Loss   (6,050,656) (6,050,656)
Ending Balance at Mar. 31, 2019 $ 13 $ 341,529 30,712,228 (49,941,101) (18,887,331)
Ending Balance, Shares at Mar. 31, 2019 13,000 341,529,434      
Beginning Balance at Dec. 31, 2018 $ 13 $ 341,529 30,669,220 (43,890,445) (12,879,683)
Beginning Balance, Shares at Dec. 31, 2018 13,000 341,529,434      
Share-based compensation from issuance of options and compensation-based warrants         575,145
Net Loss         (5,881,564)
Ending Balance at Sep. 30, 2019 $ 13 $ 344,029 31,259,865 (49,772,009) (18,168,602)
Ending Balance, Shares at Sep. 30, 2019 13,000 341,529,434      
Beginning Balance at Mar. 31, 2019 $ 13 $ 341,529 30,712,228 (49,941,101) (18,887,331)
Beginning Balance, Shares at Mar. 31, 2019 13,000 341,529,434      
Share-based compensation from issuance of options and compensation-based warrants 460,395 460,395
Exercise of stock options
Net Loss   146,690 146,690
Ending Balance at Jun. 30, 2019 $ 13 $ 341,529 31,172,623 (49,794,411) (18,280,246)
Ending Balance, Shares at Jun. 30, 2019 13,000 341,529,434      
Share-based compensation from issuance of options and compensation-based warrants 74,742 74,742
Exercise of stock options $ 2,500 12,500 15,000
Exercise of stock options, Shares 2,500,000      
Net Loss 22,402 22,402
Ending Balance at Sep. 30, 2019 $ 13 $ 344,029 31,259,865 (49,772,009) (18,168,602)
Ending Balance, Shares at Sep. 30, 2019 13,000 341,529,434      
Beginning Balance at Dec. 31, 2019 $ 13 $ 344,029 31,259,365 (55,682,264) (24,078,857)
Beginning Balance, Shares at Dec. 31, 2019 13,000 344,029,434      
Share-based compensation from issuance of options and compensation-based warrants 25,614 25,614
Exercise of stock options $ 8,177 63,419 71,596
Exercise of stock options, Shares 8,177,315      
Net Loss 5,438,024 5,438,024
Ending Balance at Mar. 31, 2020 $ 13 $ 352,206 31,348,398 (50,244,240) (18,543,623)
Ending Balance, Shares at Mar. 31, 2020 13,000 352,206,749      
Beginning Balance at Dec. 31, 2019 $ 13 $ 344,029 31,259,365 (55,682,264) (24,078,857)
Beginning Balance, Shares at Dec. 31, 2019 13,000 344,029,434      
Share-based compensation from issuance of options and compensation-based warrants         189,938
Net Loss         (3,401,075)
Ending Balance at Sep. 30, 2020 $ 13 $ 358,499 37,003,306 (59,083,339) (21,721,521)
Ending Balance, Shares at Sep. 30, 2020 13,000 358,499,606      
Beginning Balance at Mar. 31, 2020 $ 13 $ 352,206 31,348,398 (50,244,240) (18,543,623)
Beginning Balance, Shares at Mar. 31, 2020 13,000 352,206,749      
Share-based compensation from issuance of options and compensation-based warrants 155,186 155,186
Exercise of stock options $ 6,293 12,907 19,200
Exercise of stock options, Shares 6,292,857      
Option grants for investment in subsidiaries 5,477,677 5,477,677
Net Loss (3,411,517) (3,411,517)
Ending Balance at Jun. 30, 2020 $ 13 $ 358,499 36,994,168 (53,655,757) (16,303,077)
Ending Balance, Shares at Jun. 30, 2020 13,000 358,499,606      
Share-based compensation from issuance of options and compensation-based warrants 9,138 9,138
Net Loss (5,427,582) (5,427,582)
Ending Balance at Sep. 30, 2020 $ 13 $ 358,499 $ 37,003,306 $ (59,083,339) $ (21,721,521)
Ending Balance, Shares at Sep. 30, 2020 13,000 358,499,606